Investor Claims Biopharma Withheld Patient Testing Info
A shareholder in CTI Biopharma Corp. on Tuesday brought a derivative suit in Washington federal court accusing the company's executives of withholding information about patient deaths during clinical trials for its...To view the full article, register now.
Already a subscriber? Click here to view full article